What is a noted side effect of Ticagrelor (Brilinta) used in cardiac procedures?

Ticagrelor, a potent antiplatelet medication, has been noted to cause shortness of breath as a side effect in some patients. This occurs in a minority of individuals and is thought to be related to its mechanism of action, which can lead to increased levels of adenosine. Elevated adenosine levels can result in bronchoconstriction, particularly in patients with underlying respiratory conditions, or may lead to subjective feelings of dyspnea even in those without prior respiratory problems. In clinical practice, it is essential for healthcare providers to recognize this side effect, as it can affect patient adherence to therapy and may require monitoring or intervention.

The other choices, while they can occur with various medications, are not specifically highlighted as a notable side effect of Ticagrelor in the same way that shortness of breath is documented in clinical literature. Understanding the spectrum of side effects associated with Ticagrelor, particularly respiratory symptoms, is crucial for effective patient management in cardiovascular care.